Chiesi dumps uniQure’s hemophilia B gene therapy – FierceBiotech
FierceBiotech |
Chiesi dumps uniQure's hemophilia B gene therapy
FierceBiotech Chiesi has cut its ties to uniQure's hemophilia B gene therapy. The split gives uniQure full rights to AMT-060 but leaves it without a partner to cofund R&D as it closes in on the start of a pivotal trial. Italian drugmaker Chiesi picked up the rights … |
